Skip to main content

Table 1 Demographics (Mean ± SD) of Non-Hispanic White Subjects in SPIROMICS

From: Genome-wide association study of lung function and clinical implication in heavy smokers

 

Cases

Controls

P value

 

All

Current smokers

Former smokers

All

Current smokers

Former smokers

 

n

1086

325

761

559

210

349

NA

Age at enrollment, years

66.2 ± 7.6

62.9 ± 8.1

67.7 ± 6.9

63.6 ± 9.0

58.0 ± 9.1

66.9 ± 7.0

< 0.0001

Female, n (%)

437 (40)

137 (42)

300 (39)

294 (53)

122 (58)

172 (49)

< 0.0001

Body mass index

27.4 ± 5.1

25.7 ± 4.9

28.1 ± 5.0

28.6 ± 5.0

27.5 ± 5.1

29.2 ± 4.8

< 0.0001

Current smokers, n (%)

325 (30)

325 (100)

0 (0)

210 (38)

210 (100)

0 (0)

0.0019

Pack-years of cigarette smoking

55.0 ± 25.7

52.6 ± 24.7

56.0 ± 26.1

46.3 ± 27.3

45.3 ± 31.1

46.9 ± 24.8

< 0.0001

Post-bronchodilator FEV1/FVC

0.52 ± 0.13

0.55 ± 0.11

0.50 ± 0.13

0.77 ± 0.05

0.78 ± 0.05

0.77 ± 0.05

< 0.0001

Post-bronchodilator FEV1, % predicted

60.1 ± 22.5

63.6 ± 19.7

58.6 ± 23.5

94.4 ± 13.9

93.4 ± 13.2

95.0 ± 14.3

< 0.0001

  1. Subjects with available GWAS genotyping information available at current stage were included; Cases: GOLD stage 1–4; Controls: GOLD stage 0